Increased intracellular and extracellular oxidant production in phagocytes of rheumatic patients treated with biological therapy – whole blood quantification

Bjorkman L, Dahlgren C, Karlsson A, Brown KL, Bylund J. (2008). Phagocyte-derived reactive oxygen species as suppressors of inflammatory disease. Arthritis Rheum58: 2931–2935.10.1002/art.23941Open DOISearch in Google Scholar

Bylund J, Brown KL, Movitz C, Dahlgren C, Karlsson A. (2010). Intracellular generation of superoxide by the phagocyte NADPH oxidase: How, where, and what for? Free Rad Biol Med48: 1834–1845.10.1016/j.freeradbiomed.2010.09.016Search in Google Scholar

Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M. (2005). Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther7: R250–R255.10.1186/ar1477Open DOISearch in Google Scholar

Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. (1999). J Immunol Methods232: 3–14.10.1016/S0022-1759(99)00146-5Search in Google Scholar

Dahlgren C, Karlsson A, Bylund J. (2007). Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol412: 349–363.Search in Google Scholar

Den Broeder AA, Wanten GJA, Oyen WJG, Naber T, van Riel PLCM, Barrera P. (2003). Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-α monoclonal antibody in patients with rheumatoid arthritis. J Rheumatol30: 232–237.Search in Google Scholar

Hartmann P, Franzen C, Rubbert A, Rogowski J, Kailus M, Salzberger B. (2005). Blockade of TNF does not alter oxygen burst and phagocytosis of human neutrophils in patients with rheumatoid arthritis. Immunobiology209: 669–679.Search in Google Scholar

Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R. (2009). The protective role of ROS in autoimmune disease. Trends Immunol30: 201–208.10.1016/j.it.2009.03.00419356981Open DOISearch in Google Scholar

Jančinová V, Drábiková K, Nosáľ R, Račková L, Májeková M, Holomáňová D. (2006). The combined luminol/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils. Redox Rep11: 110–116.10.1179/135100006X11659216805965Open DOISearch in Google Scholar

Kolaczkowska E, Kubes P. (2013). Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol13: 159–175.10.1038/nri339923435331Open DOISearch in Google Scholar

Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW. (2002). Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol103: 13–21.Search in Google Scholar

Nakamura M, Nakamura S. (1998). One- and two-electron oxidations of luminol by peroxidase systems. Free Rad Biol Med24: 537–544.Search in Google Scholar

Rájecký M, Lojek A, Číž M. (2012). Differentiating between intra- and extra-cellular chemiluminescence in diluted whole-blood samples. Int J Lab Hem34: 136–142.10.1111/j.1751-553X.2011.01370.x21834798Open DOISearch in Google Scholar

Ristola M, Repo H. (1989). Luminol-enhanced chemiluminescence of whole blood. APMIS97: 503–512.10.1111/j.1699-0463.1989.tb00823.xOpen DOISearch in Google Scholar

Sedger LM, McDermott MF. (2014). TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future. Cytokine Growth Factor Rev25: 453–472.Search in Google Scholar

Semerano L, Minichiello E, Bessis N, Boissier MC. (2016). Novel immunotherapeutic avenues for rheumatoid arthritis. Trends Mol Med22: 214–229.10.1016/j.molmed.2016.01.00526875450Open DOISearch in Google Scholar

Thieblemont N, Wright HL, Edwards SW, Witko-Sarsat V. (2016). Human neutrophils in auto-immunity. Semin Immunol28: 159–173.10.1016/j.smim.2016.03.00427036091Open DOISearch in Google Scholar